FDA Delays OKing Shire's Eye Drug As Baxalta Bid Dangles
Irish pharmaceutical company Shire PLC has disclosed that the U.S. Food and Drug Administration has sought more clinical study data on its application to market a medication to treat dry eye...To view the full article, register now.
Already a subscriber? Click here to view full article